To evaluate the in vivo therapeutic efficacy of TF-targeted NIR-PIT, we employed the HPAF-II pancreatic cancer model (Fig. 3D), in which high TF expression was observed (Fig. S4). The gene discussed is TF; the disease is familial pancreatic carcinoma.